Events & Presentations

Ablynx participates and presents at scientific conferences.

Upcoming IR Events

No events currently exist in this section.

Recent IR Presentations

No events currently exist in this section.

Upcoming Scientific Events

64th ISTH (International Society on Thrombosis and Haemostasis) Conference
18-21 July 2018 - Dublin, Ireland

6th Annual Immuno-Oncology Summit
27-31 August 2018 - Boston, (MA), USA

Europe Biobank Week
4-7 September 2018 - Antwerp, Belgium

Recent Scientific Presentations

"Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura", presented by Professor Marie Scully in the late-breaking abstracts session at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA, USA
12 December 2017 - Atlanta (GA), USA

pdf version of the presentation

Poster "Results of a Phase 2b Study of Vobarilizumab, an Anti-Interleukin 6 Receptor Nanobody®, as Monotherapy in Patients with Moderate-to-Severe Rheumatoid Arthritis" presented at the European Congress of Rheumatology (EULAR)
14-17 June 2017 - Madrid, Spain

pdf version of the presentation

Presentation "Remission and Maintenance of Efficacy in a Phase 2b study of Vobarilizumab, an Anti-Interleukin 6 Receptor Nanobody®, in Patients with Moderate-to-Severe Rheumatoid Arthritis despite Treatment with Methotrexateat" presented at the European Congress of Rheumatology (EULAR)
14-17 June 2017 - Madrid, Spain

pdf version of the presentation